This morning’s pre-close trading update highlights revenue slightly ahead of consensus estimates for FY2015 and expected revenue at the higher end of the consensus range for FY2016. We have adjusted our revenue estimate from £1.8m to £1.3m for the current year, but upgraded estimates for FY2016-17. In addition, the selection of Midatech’s glioblastoma programme for compassionate use is exciting news: we look forward to tumour response data around mid-year, which could trigger significant interes ....
06 Jan 2016
Trading update and plans for compassionate use
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Trading update and plans for compassionate use
- Published:
06 Jan 2016 -
Author:
Dr Jens Lindqvist -
Pages:
3
This morning’s pre-close trading update highlights revenue slightly ahead of consensus estimates for FY2015 and expected revenue at the higher end of the consensus range for FY2016. We have adjusted our revenue estimate from £1.8m to £1.3m for the current year, but upgraded estimates for FY2016-17. In addition, the selection of Midatech’s glioblastoma programme for compassionate use is exciting news: we look forward to tumour response data around mid-year, which could trigger significant interes ....